Best in 7 days
Pay in installments of $6.21 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Chart: 1 in 8 Americans Now Use GLP 1 Drugs for Weight Loss Statista I Lost 160 Pounds Through Bariatric Weight Loss Surgery' Tu cuerpo ya produce una hormona que ayuda a regular la glucosa despus de comer se llama GLP 1. Por eso existen medicamentos que imitan su accin y se utilizan en el tratamiento Medicaid Coverage of and Spending on GLP 1s KFF Rudowitz, Robin Mean 6 SD postprandial plasma glucagon like peptide 1 (GLP 1) levels Download Scientific Diagram
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Discover Niche Categories That Outsell will compounded semaglutide still be available
Top-Converting Item to Boost Your Average Order
Best in 7 days
Best in 7 days
Best in 7 days
Best in 7 days
4.5 ★★★★★
Based on 852 reviews
Sort
Product Reviews
★★★★★ 3
Partly still thought-provoking, partly dated
Format: Paperback
Dr. Wittig had so much anger, and had such a fight to fight. She seems excessive at times, or as though she is painting with such a broad brush, but writing such as this did win some important battles. No, things are not as dark as her wrath would suggest, or at least not anymore.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 4, 2013
★★★★★ 5
You will laugh and cry
Format: Kindle
Luckily, I stumbled into a link to this book on Transfeminine Review. One warning: take your eye makeup off before reading. You will laugh till you cry and that is not a good look with mascara.
The plot resembles the movie American Fiction. Pearl is an aspiring trans woman writer. Her first novel has sunk without a trace so now she is going to try something more commercial: a gay male romance with James Bond action marketed to straight women who love that kind of thing. She's even adopting a pen name as Paul Sisters, s gay man.
For a time it works. She has a publisher, Muzzle And Escutcheon is selling well and "Paul" has a fan following. Still, it's getting harder and harder to maintain her fake identity and she's having to make ever more compromises with her own identity and relationships.
One other caution. Pearl does have to deal with casual transphobia. One sequence of her doing an online chat as Paul with transphobic fans and trying not to let it get to her I foundto be particularly triggering
Good, funny, recommended
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 19, 2025
★★★★★ 5
Brilliantly written
Format: Kindle
I read this in a single sitting, mesmerized. I cared about the protagonist even as she made increasingly bad and soul damaging decisions. I love love love her girlfriend and her roommate is also fun. One could argue that the humorous elements convey the dangers of being a trans woman in both publishing and life especially well. I also enjoyed the publishing scene aspects like in Yellowface. A great read. I’m now a fan!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 6, 2025
★★★★★ 5
got it
Format: Hardcover
got it when i was supposed to but can't review it anymore as it was a gift. it would be nice to just be able to star something & not HAVE TO write 20 words.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 30, 2013
★★★★★ 5
Great gift!
Format: Hardcover
Really nice quality, good illustrations. My boyfriend loved it.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 29, 2016
